TITLE

Levalbuterol Oral Inhalation

PUB. DATE
June 2020
SOURCE
AHFS Consumer Medication Information;Jun2020, p1
SOURCE TYPE
Database
DOC. TYPE
Article
ABSTRACT
Levalbuterol is used to prevent or relieve the wheezing, difficulty breathing, and chest tightness caused by lung disease such as asthma and chronic obstructive pulmonary disease (COPD; a group of diseases that affect the lungs and airways). Levalbuterol is in a class of medications called beta agonists. It works by relaxing and opening air passages to the lungs to make breathing easier.
ACCESSION #
78170050

 

Related Articles

  • Single LABA inhalers potentially unsafe. Cameron, Amanda // New Zealand Doctor;6/14/2006, p12 

    Reports on the claim of respiratory physician Richard Beasley that single asthma inhalers that dispense a long-acting beta agonist (LABA) are potentially unsafe when used in unstable patients without inhaled corticosteroids treatment. Physiological effect of single LABA inhalers; Information on...

  • Use LABAs only when asthma cannot be controlled otherwise. Hasford, Joerg; Currie, Graeme P.; Douglas, Graham // BMJ: British Medical Journal;11/9/2013, Vol. 347 Issue 7932, p21 

    A letter to the editor, as well as a response by Graeme P. Currie and Graham Douglas to the letter about their article "Long Acting β2 Agonists in Adult Asthma" are presented.

  • Beta [sub 2] Agonists and asthma. Rees, John // BMJ: British Medical Journal (International Edition);5/18/91, Vol. 302 Issue 6786, p1166 

    Investigates the role of Beta[sub 2] agonists in managing asthma. Conduction of meeting of doctors and representatives of pharmaceutical companies; Infusion of drug for symptotic relief; Increase responsiveness to airway challenges.

  • Impact of over-the-counter availability of beta2 agonists.  // American Family Physician;11/1/1993, Vol. 48 Issue 6, p1150 

    Reports on the study by Gibson and colleagues concerning the relationship between the availability of beta2 selective agonists without prescription and treatment of asthma. Publication of article in the June 5, 1993 issue of the `British Medical Journal'; Correlation between undertreatment and...

  • Combining Salbutamol with Salmeterol Does Not Influence Bronchodilation.  // Modern Medicine;Oct98, Vol. 66 Issue 10, p52 

    Discusses the abstract of the article `Effect of salmeterol is independent of previously inhaled salbutamol: A clinical controlled study,' by J.T.R. Wilcke, E.T. Iversen and A. Kok-Jensen, published in the February 1998 issue of the `Lung' periodical.

  • LABAs: not to be used alone.  // Monthly Prescribing Reference;Mar2010, Vol. 26 Issue 3, pA18 

    The article reports that the use of long-acting beta agonists (LABAs) are associated with an increased risk of severe worsening of asthma symptoms and may cause hospitalization and death, thus, they should never be used alone to treat asthma.

  • Review: inhaled long acting β2 agonists are effective and safe in stable chronic asthma. Parameswaran, Krishnan // Evidence Based Medicine;Sep/Oct2004, Vol. 9 Issue 5, p139 

    The article provides an answer to a question about the effectiveness of β2 in treating chronic asthma.

  • Medical Therapy for Asthma: Updates from the NAEPP Guidelines. ELWARD, KURTIS S.; POLLART, SUSAN M. // American Family Physician;2015 Special Issue, Vol. 91, p1 

    Proper care of patients with asthma involves the triad of systematic chronic care plans, self-management support, and appropriate medical therapy. Controller medications (inhaled corticosteroids, long-acting beta2 agonists, and leukotriene receptor antagonists) are the foundation of care for...

  • A Comparison of Fluticasone Propionate, 100µg Twice Daily, Administered Via a CFC and Non-CFC Propellant, HFA 134a, in Adult Patients with Asthma. Stone, D.W.G.; Mairs, M.L.; Willits, L.; Sharma, R.K. // Clinical Drug Investigation;2001, Vol. 21 Issue 10, p695 

    Objective: This study was designed to demonstrate equivalent efficacy and similar tolerability of a fluticasone propionate (FP) 50μg hydrofluoroalkane HFA 134a formulation with that of the established chlorofluorocarbon (CFC) 50μg formulation in adult patients with asthma. Design and...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics